Deepak Srivastava is president of Gladstone Institutes, director of the Roddenberry Stem Cell Center at Gladstone and is an attending pediatric cardiologist in UCSF’s Benioff Children’s Hospital. He leads an elite biomedical research institute focused on heart, brain, viral and immunologic diseases, leveraging cutting edge technologies and data science to overcome some of humankind’s most devastating conditions. In addition to overseeing Gladstone, Srivastava has identified several genetic causes of human heart disease and developed novel approaches for heart regeneration. He has co-founded several biotechnology companies in the Bay Area to advance discoveries into clinical trials.
Srivastava completed his undergraduate degree at Rice University, medical training at the University of Texas, residency in pediatrics at UCSF and fellowship in pediatric cardiology at the Children’s Hospital of Harvard Medical School. He has published over 200 scientific papers and trained over 50 scientists, many leading their own groups across the world. In addition to receiving many awards. Srivastava has been elected to the American Academy of Arts and Sciences and the National Academy of Medicine, and he is the immediate past president of the International Society for Stem Cell Research.